158 related articles for article (PubMed ID: 2268535)
1. Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice.
Borsi JD; Sagen E; Romslo I; Moe PJ
Pediatr Hematol Oncol; 1990; 7(4):347-63. PubMed ID: 2268535
[TBL] [Abstract][Full Text] [Related]
2. l-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in children.
Etienne MC; Thyss A; Bertrand Y; Touraine R; Rubie H; Robert A; Milano G
J Natl Cancer Inst; 1992 Aug; 84(15):1190-5. PubMed ID: 1635087
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate with folinic acid rescue.
Bender JF; Grove WR; Fortner CL
Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
[TBL] [Abstract][Full Text] [Related]
4. Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.
Cohen IJ
J Pediatr Hematol Oncol; 2004 Mar; 26(3):156-63. PubMed ID: 15125607
[TBL] [Abstract][Full Text] [Related]
5. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
6. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).
Cohen IJ
Med Hypotheses; 2013 Nov; 81(5):942-7. PubMed ID: 24035689
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
[TBL] [Abstract][Full Text] [Related]
8. How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia.
Borsi JD; Wesenberg F; Stokland T; Moe PJ
Eur J Cancer; 1991; 27(8):1006-9. PubMed ID: 1832883
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
10. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
Cohen IJ; Wolff JE
Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical study.
Dady PJ; Taylor GA; Muindi JF; Calvert AH; Smith IE; Smyth JF; Harrap KR
Cancer Treat Rep; 1981; 65 Suppl 1():37-43. PubMed ID: 7326664
[TBL] [Abstract][Full Text] [Related]
12. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
13. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
[TBL] [Abstract][Full Text] [Related]
14. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment.
Tubiana-Mathieu N; Monjanel-Mouterde S; Lejeune C; Payet B; Catalin J; Carcassonne Y; Cano J
Eur J Cancer; 1994; 30A(9):1281-4. PubMed ID: 7999413
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.
Joyce DA; Will RK; Hoffman DM; Laing B; Blackbourn SJ
Ann Rheum Dis; 1991 Dec; 50(12):913-4. PubMed ID: 1768158
[TBL] [Abstract][Full Text] [Related]
17. Folinic acid rescue used routinely in psoriatic patients with known methotrexate "sensitivity".
Hills RJ; Ive FA
Acta Derm Venereol; 1992 Nov; 72(6):438-40. PubMed ID: 1362837
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue.
Sessa C; de Jong J; D'Incalci M; Hatty S; Pagani O; Cavalli F
Clin Cancer Res; 1996 Jul; 2(7):1123-7. PubMed ID: 9816277
[TBL] [Abstract][Full Text] [Related]
19. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
20. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
Buckley LM; Vacek PM; Cooper SM
J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]